Latest Articles
Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis.
[This corrects the article DOI: 10.1371/journal.pone.0057724.].
Published: Feb. 17, 2026, midnight
Clinical usefulness of E4-phytohemagglutinin reactive C4-binding protein relative front value in serum for distinguishing between ovarian clear cell adenocarcinoma and endometrioma.
We identified a fully sialylated glycopeptide of the α-chain of Complement 4 binding protein (C4BP) in blood using Liquid chromatography/Mass spectrometry, which helps differentiate ovarian clear cell carcinoma (OCCC) from …
Published: Feb. 28, 2025, midnight
Endometriosis-associated primary clear cell adenocarcinoma of the urinary bladder: A case report and literature review.
Primary clear cell adenocarcinoma (CCA) of the urinary bladder is a rare and aggressive malignancy. Few reports in the literature describe this presentation, as associated with malignant transformation of endometriosis. …
Published: Dec. 20, 2024, midnight
Link copied to clipboard!